Enzalutamide in Metastatic Prostate Cancer before ChemotherapyTomasz M. Beer, Bertrand Tombal, Andrew J. Armstrong et al.|New England Journal of Medicine|2014Cited by 3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I. Scher, Andrew J. Armstrong, Elisabeth I. Heath et al.|Journal of Clinical Oncology|2016Cited by 1.6k
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal MarkersAndrew J. Armstrong, Mariano A. García-Blanco|Molecular Cancer Research|2011Cited by 650
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL StudyTomasz M. Beer, Bertrand Tombal, Andrew J. Armstrong et al.|European Urology|2016Cited by 414
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J. Armstrong, Daniel J. George, Susan Halabi et al.|Journal of Clinical Oncology|2019Cited by 364